Eric Jonasch

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Tables S7 from Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape

10.1158/1078-0432.22468029.v1

Top 100%

0DataRank

Top 100%0 citations

Tae Beom Kim, Bo Peng, Jose Karam, Chad Creighton, Aron Joon +18 more

Papers

Driven by 29 papers — median percentile 0. Top paper: “High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types”.

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Annals of Oncology(2021)10.1016/j.annonc.2021.02.006

N/A

10.8DataRank · unranked

1072 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +11 more

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages

Cell(2021)10.1016/j.cell.2021.04.038

N/A

9.0DataRank · unranked

379 citations

Nivedita Chowdhury, Scott M. Haake, Casey R. Ager, Vinson Wang, Lukas Vlahos +12 more

Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial

The Lancet Oncology(2021)10.1016/s1470-2045(21)00528-3

N/A

6.1DataRank · unranked

167 citations

Pavlos Msaouel, Kieko Hara, Haesun Choi, Venus Le, Amishi Y Shah +13 more

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease

New England Journal of Medicine(2021)10.1056/nejmoa2103425

N/A

4.7DataRank · unranked

664 citations

Frede Donskov, Othon Iliopoulos, W. Kimryn Rathmell, Vivek K. Narayan, Benjamin L. Maughan +10 more

Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00389-9

N/A

1.0DataRank · unranked

37 citations

Ane B. Iversen, Vivek Narayan, Benjamin L Maughan, Kathryn E. Beckermann, Stéphane Oudard +10 more

Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00099-3

N/A

0.741DataRank · unranked

27 citations

Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L Maughan, Stéphane Oudard +9 more

Testicular Cancer, Version 2.2015

Journal of the National Comprehensive Cancer Network(2015)10.6004/jnccn.2015.0092

N/A

0.732DataRank · unranked

131 citations

Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger +27 more

A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy

Science Translational Medicine(2022)10.1126/scitranslmed.abm6420

N/A

0.633DataRank · unranked

67 citations

Sangeeta Goswami, Peter F. Thall, Xuemei Wang, Ying Yuan, Eric Jonasch +21 more

Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease

World Journal of Urology(2020)10.1007/s00345-020-03441-3

N/A

0.571DataRank · unranked

44 citations

Melissa McGettigan, Nainesh Parikh, Ronald S. Boris, Othon Iliopoulos, W. Kimryn Rathmell +4 more

Summary From the First Kidney Cancer Research Summit, September 12–13, 2019: A Focus on Translational Research

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa064

N/A

0.557DataRank · unranked

40 citations

Michael B. Atkins, Ziad Bakouny, Maria I. Carlo, Charles G. Drake, Eric Jonasch +15 more

Axitinib in the Treatment of Metastatic Renal Cell Carcinoma

Future Oncology(2011)10.2217/fon.11.107

N/A

0.546DataRank · unranked

37 citations

Eric Jonasch, Thai H Ho

Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies

The Oncologist(2021)10.1002/onco.13770

N/A

0.546DataRank · unranked

37 citations

Tharakeswara Bathala, Andrew W. Hahn, Lianchun Xiao, Munevver Duran, Jeremy A. Ross +6 more

VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis

Journal of Clinical Investigation(2024)10.1172/jci173934

N/A

0.477DataRank · unranked

23 citations

Matthew Z. Madden, Emily N. Arner, Jackie E. Bader, Xiang Ye, Logan Vlach +18 more

SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1003

N/A

0.442DataRank · unranked

18 citations

Yanting Zhang, Daniel J. McGrail, X. Zhang, Truong Lam, Anh Hoang +11 more

Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay

Annals of Oncology(2022)10.1016/j.annonc.2022.07.009

N/A

0.330DataRank · unranked

8 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +8 more

Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al.

Annals of Oncology(2021)10.1016/j.annonc.2021.06.017

N/A

0.165DataRank · unranked

2 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +8 more

Genomic instability and DNA damage repair in clear cell renal cell carcinoma.

Journal of Clinical Oncology(2017)10.1200/jco.2017.35.15_suppl.4581

N/A

0.165DataRank · unranked

2 citations

Lijun Zhou, Pan Tong, Surena F. Matin, Kanishka Sircar, Pheroze Tamboli +5 more

Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2592

N/A

0DataRank · unranked

28 citations

Eric Jonasch, Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L. Maughan +10 more

Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease

Ophthalmology(2024)10.1016/j.ophtha.2024.05.024

N/A

0DataRank · unranked

16 citations

Ramaprasad Srinivasan, Jodi K. Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen, Anders Kruse +19 more

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.022

N/A

0DataRank · unranked

5 citations

Salvatore La Rosa, Tian Zhang, Phillip M. Pierorazio, Laurence Albigès, Kathryn E. Beckermann +19 more

Tumor diameter response in patients with metastatic clear cell renal cell carcinoma is associated with overall survival

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.08.022

N/A

0DataRank · unranked

9 citations

Daniel D. Shapiro, Mary E. Westerman, Hyunsoo Hwang, Xuemei Wang, Luis Segarra +7 more

Corrigendum

Ophthalmology(2025)10.1016/j.ophtha.2024.12.032

N/A

0DataRank · unranked

0 citations

Ramaprasad Srinivasan, Jodi K. Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen, A. Kruse +13 more

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

The Oncologist(2025)10.1093/oncolo/oyaf138

N/A

0DataRank · unranked

0 citations

Neil J. Shah, Matthew T. Campbell, Naomi B. Haas, Ariel Ann Nelson, Moshe Chaim Ornstein +12 more

Supplementary Tables S7 from Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape

10.1158/1078-0432.22468029.v1

Top 100%

0DataRank

Top 100%0 citations

Tae Beom Kim, Bo Peng, Jose Karam, Chad Creighton, Aron Joon +18 more

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

Cancers(2021)10.3390/cancers13061475

N/A

0DataRank · unranked

16 citations

Anupama Reddy, Stephanie O. Dudzinski, Aaron R. Lim, Ayaka Sugiura, Rachel A. Hongo +26 more

Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation

British Journal of Urology(2021)10.1111/bju.15541

N/A

0DataRank · unranked

33 citations

Aradhana M. Venkatesan, Pavlos Msaouel, Amol J. Ghia, Jing Li, D.N. Yeboa +13 more

Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature

The Lancet Diabetes & Endocrinology(2020)10.1016/s2213-8587(20)30363-6

N/A

0DataRank · unranked

68 citations

Elizabeth J. Atkinson, Charis Eng, William F. Young, Hartmut P.H. Neumann, M. Yu. Yukina +95 more

Chronic hepatitis C virus infection and genitourinary cancers: A case-control study

Seminars in Oncology(2020)10.1053/j.seminoncol.2020.04.005

N/A

0DataRank · unranked

0 citations

Parag Mahale, Eric Jonasch, Ying Jiang, Harrys A. Torres, Georgios Angelidakis

Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy

Angiogenesis(2022)10.1007/s10456-022-09863-4

N/A

0DataRank · unranked

53 citations

Judy R. van Beijnum, Christian J. Griffioen, Zowi R. Huinen, Nadine Grima Sopesens, Ralph Schulz +13 more

Eric Jonasch

Indexed papers

Top data-sharing exemplar

Papers